FY2023 · ended Jan 31, 2023 · Revenue $67,996, -26.1% YoY · Filed Jun 9, 2023
Neutra Corp. (NTRR) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2023, which ended Jan 31, 2023, it reported revenue of $67,996 and a net loss of $561,417.
Revenue (TTM)
$17,397
-82.7% vs year-ago TTM
Net income (TTM)
$-473,832
-2.5% vs year-ago TTM
Operating cash flow (TTM)
$-9,764
+95.3% vs year-ago TTM
Free cash flow
$-445,842
+26.8% vs prior year
EPS
—
Dividend per share
None
Shares outstanding
2.92B
+32.2% vs prior year
Net cash
$-484,686
FY 2016
Operating margin
-1457.1%
FY 2024
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NTRR (OTC)
- Fiscal year ends
- January 31
- Incorporated in
- WY
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1512886
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2023 Jan 31, 2023 |
FY 2022 Jan 31, 2022 |
FY 2021 Jan 31, 2021 |
FY 2020 Jan 31, 2020 |
FY 2019 Jan 31, 2019 |
|---|---|---|---|---|---|
| Revenue | $67,996 | $92,014 | $9,687 | $6,395 | — |
| Operating income | -$297,675 | -$583,582 | -$478,665 | -$394,245 | -$1.7M |
| Net income | -$561,417 | -$632,926 | -$538,892 | -$695,621 | -$2.4M |
| Operating cash flow | -$153,243 | -$405,615 | -$412,378 | -$181,607 | -$417,000 |
| Free cash flow | — | -$445,842 | -$608,868 | — | — |
| Total assets | $75,175 | $130,932 | $190,767 | $182,334 | $163,596 |
| Total liabilities | $813,795 | $1.2M | $1.0M | $1.0M | $1.3M |
| Stockholders' equity | -$773,820 | -$1.3M | -$967,476 | -$849,490 | -$1.1M |
| Cash and investments | $1,969 | $1,056 | $23,308 | $177,176 | $0 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2024 | Apr 30, 2024 |
| 10-K | Annual report | Aug 2, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Auditor change
|
May 15, 2024 | May 3, 2024 |
| 10-Q | Quarterly report | Dec 15, 2023 | Oct 31, 2023 |
| 10-Q | Quarterly report | Sep 14, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Auditor change
|
Aug 4, 2023 | Aug 1, 2023 |
All 160 Neutra Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.